Newsfeeds - Spark Newswire

2 minute read

22 Stocks Moving in Friday’s Pre-Market Session

Today, 11:06 AM

Gainers Moving iMage Technologies, Inc. (NASDAQ: MITQ) rose 41.7% to $1.63 in pre-market trading. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming and e-Sports.

AMPE

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:06 AM

Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.

2 minute read

Mid-Afternoon Market Update: Nasdaq Down 200 Points; United Airlines Shares Jump

By Lisa Levin

Today, 11:06 AM

U.S. stocks turned lower toward the end of trading, with the Nasdaq dropping 200 points on Thursday.

AMPE

3 minute read

Mid-Day Market Update: Nasdaq Turns Negative; US Weekly Jobless Claims Edge Lower

By Lisa Levin

Today, 11:06 AM

U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday.

AMPE

3 minute read

30 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 11:06 AM

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) shares gained 34.3% to $5.72. Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares climbed 19.3% to $10.62.

3 minute read

26 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 11:06 AM

Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.

2 minute read

Ampio Pharma Offers Regulatory Update, Says FDA Did Not Agree With Co.’s Proposed Changes To Its AP-013 Trial And, As Such, ‘it will be very difficult to salvage AP-013 itself as a pivotal trial’

By Benzinga Newsdesk

Today, 11:06 AM

Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potentially other

AMPE

1 minute read

UPDATE: Ampio Pharmaceuticals Q4 Adj. EPS $(0.04) Misses $(0.02) Estimate

By Benzinga Newsdesk

Today, 11:06 AM

Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 100 percent decrease over losses of $(0.02) per share from

AMPE

5 minute read

Earnings Scheduled For March 29, 2022

By Benzinga Insights

Today, 11:06 AM

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

AMPE

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

By Shanthi Rexaline

Today, 11:06 AM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP